Exhibit 4.6 AMENDING AGREEMENT THIS AGREEMENT is made as of March 31, 2003 B E T W E E N: DRAXIS HEALTH INC., a corporation incorporated under the laws of Canada (hereinafter referred to as "Draxis")License, Distribution and Supply Agreement • May 14th, 2003 • Draxis Health Inc /Cn/ • Pharmaceutical preparations • Delaware
License, Distribution and Supply Agreement to market Cholecalciferol in China, Hong Kong, Macau and TaiwanLicense, Distribution and Supply Agreement • September 8th, 2014
Hong Kong, 8 September 2014 - Lee’s Pharmaceutical Holdings Limited (“the Group” or “Lee’s”) (Main Board Stock Code: 0950; Website: www.leespharm.com) and Abiogen Pharma S.p.A. of Pisa, Italy today jointly announced the signing of an agreement for License, Distribution and Supply for marketing of Thorens® Cholecalciferol (or vitamin D3) throughout China, Hong Kong, Macau and Taiwan.
BETWEEN:License, Distribution and Supply Agreement • June 29th, 2001 • Draxis Health Inc /Cn/ • Pharmaceutical preparations • Delaware
License, Distribution and Supply Agreement to market Neridronic Acid in China, Hong Kong, Macau and TaiwanLicense, Distribution and Supply Agreement • April 11th, 2014
Hong Kong, 11 April 2014 - Lee’s Pharmaceutical Holdings Limited (“the Group” or “Lee’s”) (Main Board Stock Code: 0950; Website: www.leespharm.com) and Abiogen Pharma S.p.A. of Pisa, Italy today jointly announced the signing of an agreement for License, Distribution and Supply for marketing of Attila® (Neridronic Acid) throughout China, Hong Kong, Macau and Taiwan.
LICENSE, DISTRIBUTION AND SUPPLY AGREEMENTLicense, Distribution and Supply Agreement • August 8th, 2022 • PolyPid Ltd. • Surgical & medical instruments & apparatus • London
This License, Distribution and Supply Agreement (the “Agreement”) is entered into as of 2nd of August 2022 (the “Effective Date”), by and between PolyPid Ltd., a company existing under the laws of Israel, having offices at 18 Hasivim St. Petach Tikva 4917002, Israel (“PolyPid”), and Mercury Pharma Group Limited, under the trade name Advanz Pharma Holdings, a corporation organized under the laws of England, having its registered office at Capital House, 85 King William Street, London, EC4N 7BL, United Kingdom (“Partner”) and shall become effective on the Effective Date. PolyPid and Partner are sometimes referred to collectively herein as the “Parties” or singly as a “Party.”
